PharmAla Biotech Provides Corporate Update: U.S. Patent Granted Covering Novel Enantioselective Processes, Decision on APA-01, and Engagement of Canaccord Genuity as Exclusive Investment Banking Partner

globe_newswire · 2026-08-21

$APA

PharmAla Biotech provides a corporate update relating to its investment banking partner, Canaccord Genuity LLC, and its IP.

Read the original at globe_newswire ↗

Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.